CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Tanguler Tolga EVP, Chief Commercial Officer | Exercise or conversion | +1,667 | 5,737 | ||
| 2024-02-27 | Tanguler Tolga EVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −1,667 | 3,333 | ||
| 2024-02-27 | Poulton Jeffrey V. EVP, Chief Financial Officer | Exercise or conversion | +1,908 | 20,052 | ||
| 2024-02-27 | Poulton Jeffrey V. EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,908 | 3,816 | ||
| 2024-02-27 | Greenstreet Yvonne Chief Executive Officer | Exercise or conversion | +5,921 | 51,060 | ||
| 2024-02-27 | Greenstreet Yvonne Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,921 | 11,842 | ||
| 2024-02-27 | Garg Pushkal CMO & EVP Dev & Med Affairs | Exercise or conversion | +1,908 | 9,240 | ||
| 2024-02-27 | Garg Pushkal CMO & EVP Dev & Med Affairs | Exercise or conversion · Restricted Stock Units | −1,908 | 3,816 | ||
| 2024-02-27 | Franchini Indrani Lall EVP, CLO & Secretary | Exercise or conversion | +878 | 4,462 | ||
| 2024-02-27 | Franchini Indrani Lall EVP, CLO & Secretary | Exercise or conversion · Restricted Stock Units | −878 | 1,754 | ||
| 2024-02-16 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −480 | $147.50 | $71K | 8,160 |
| 2024-02-16 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −672 | $148.24 | $100K | 7,488 |
| 2024-02-16 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −156 | $149.03 | $23K | 7,332 |
| 2024-02-16 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −369 | $147.50 | $54K | 18,782 |
| 2024-02-16 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −518 | $148.24 | $77K | 18,264 |
| 2024-02-16 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −120 | $149.03 | $18K | 18,144 |
| 2024-02-16 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −369 | $147.50 | $54K | 4,710 |
| 2024-02-16 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −519 | $148.24 | $77K | 4,191 |
| 2024-02-16 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −121 | $149.03 | $18K | 4,070 |
| 2024-02-16 | Greenstreet Yvonne Chief Executive Officer | Sale | −2,576 | $147.50 | $380K | 49,593 |
Page 50 of 80 · 1,590 trades